Lilly’s Quiet $21B Sprint: Seven Deals, One Strategy Hiding in Plain Sight Shajini May 25, 2026 While the industry debated whether GLP-1 mania had peaked, Eli Lilly closed seven acquisitions in 134 days. NHS Gives Green Light to Life-Changing SMA Treatments EU Critical Medicines Act Fights Dangerous Supply Crisis February 2026 Deal Report: Five Signals from $53B in Activity Lilly to buy Ventyx for $1.2B, bolstering oral inflammation pipeline Editor’s Feature Lilly’s Quiet $21B Sprint: Seven Deals, One Strategy Hiding in Plain Sight Shajini May 25, 2026 NHS Gives Green Light to Life-Changing SMA Treatments Athithi May 15, 2026 Monthly Standout Weekly Pulse: Policy & Access Rules Rewritten for 2026 Shajini December 8, 2025 February 2026 Deal Report: Five Signals from $53B in Activity Shajini March 1, 2026 NextGen Gene Editing Breakthroughs Redefine Personalized Care Shajini November 4, 2025 Speciality Korea Unlocks Breakthrough Access for Ultomiris and Jemperli Shajini December 2, 2025 Repatha Shows Sustained CV Benefit in Largest RWE Study Shajini November 27, 2025 Ikarovec Eyes $1B Deal to Move Eye Gene Therapy In-Office Shajini January 7, 2026 NeuroPulse Neuropulse Daily: January 8, 2026 January 8, 2026 NeuroPulse Daily: January 05, 2026 January 6, 2026 NeuroPulse Today’s Signals: Personalized Neuromodulation, Pediatric Imaging Wins, and Schizophrenia IP Resets December 20, 2025 NeuroPulse Daily Brief: December 20, 2025 December 20, 2025 NeuroPulse Today’s Signals: Precision Regulation, RNA Partnerships, and Real-World Data Redefine Neuro Strategy December 19, 2025 NeuroPulse Daily Brief: December 19, 2025 December 19, 2025 Korea Unlocks Breakthrough Access for Ultomiris and Jemperli December 2, 2025 AI Wearable EPISERAS Predicts Seizures in Real Time November 28, 2025 Deal Room Lilly’s Quiet $21B Sprint: Seven Deals, One Strategy Hiding in Plain Sight May 25, 2026 February 2026 Deal Report: Five Signals from $53B in Activity March 1, 2026 Metsera responds to Pfizer lawsuit, defends board process in Novo bid dispute November 3, 2025 Novo’s unsolicited bid for Metsera challenges Pfizer pact November 3, 2025 Thermo Fisher’s Inspiring $10 Billion Acquisition of Clario October 29, 2025 Access Watch German Court Halts Merck’s Keytruda SC in Major Patent Clash December 9, 2025 Pacira Sues to Block EXPAREL Generics After ANDA Filings November 28, 2025 NHS Gives Green Light to Life-Changing SMA Treatments May 15, 2026 EU Critical Medicines Act Fights Dangerous Supply Crisis May 11, 2026 NICE backs digital asthma tools for NHS use as evidence builds January 8, 2026 What’s Next Lilly to buy Ventyx for $1.2B, bolstering oral inflammation pipeline January 8, 2026 NICE backs digital asthma tools for NHS use as evidence builds January 8, 2026 IQWiG Highlights Evidence Gaps Despite Growing Treatment Options January 8, 2026 Lilly taps InduPro’s proximity-guided platform in up to $950M oncology deal January 8, 2026 Read More
Lilly’s Quiet $21B Sprint: Seven Deals, One Strategy Hiding in Plain Sight Shajini May 25, 2026 While the industry debated whether GLP-1 mania had peaked, Eli Lilly closed seven acquisitions in 134 days.
NeuroPulse Today’s Signals: Personalized Neuromodulation, Pediatric Imaging Wins, and Schizophrenia IP Resets December 20, 2025
NeuroPulse Today’s Signals: Precision Regulation, RNA Partnerships, and Real-World Data Redefine Neuro Strategy December 19, 2025
